Novel targets for sepsis‐induced kidney injury: the glomerular arterioles and the sympathetic nervous system
暂无分享,去创建一个
R. Bellomo | C. May | C. Langenberg | R. Ramchandra | L. Wan | P. Calzavacca | K. Ishikawa
[1] R. Bellomo,et al. Effect of selective inhibition of renal inducible nitric oxide synthase on renal blood flow and function in experimental hyperdynamic sepsis* , 2012, Critical care medicine.
[2] François M Abboud,et al. Autonomic Neural Regulation of the Immune System: Implications for Hypertension and Cardiovascular Disease , 2012, Hypertension.
[3] R. Bellomo,et al. The Effects of Terlipressin on Regional Hemodynamics and Kidney Function in Experimental Hyperdynamic Sepsis , 2012, PloS one.
[4] G. Pell,et al. Renal bioenergetics during early gram-negative mammalian sepsis and angiotensin II infusion , 2012, Intensive Care Medicine.
[5] A. Jacob,et al. Ghrelin-mediated sympathoinhibition and suppression of inflammation in sepsis. , 2012, American journal of physiology. Endocrinology and metabolism.
[6] J. Chvojka,et al. Searching for mechanisms that matter in early septic acute kidney injury: an experimental study , 2011, Critical care.
[7] Can Ince,et al. The Microcirculation as a Therapeutic Target in the Treatment of Sepsis and Shock , 2011, Seminars in respiratory and critical care medicine.
[8] M. Sugimachi,et al. Centrally administered ghrelin activates cardiac vagal nerve in anesthetized rabbits , 2011, Autonomic Neuroscience.
[9] M. Rundgren,et al. Toll-like receptor 4 inhibitor TAK-242 attenuates acute kidney injury in endotoxemic sheep. , 2011, Anesthesiology.
[10] R. Bellomo,et al. The impact of intrarenal nitric oxide synthase inhibition on renal blood flow and function in mild and severe hyperdynamic sepsis* , 2011, Critical care medicine.
[11] A. Géloën,et al. Alpha-2 agonists to reduce vasopressor requirements in septic shock? , 2010, Medical hypotheses.
[12] A. Geloen,et al. Increased pressor response to noradrenaline during septic shock following clonidine? , 2010, Anaesthesia and intensive care.
[13] Tsuyoshi Mori,et al. Septic acute renal failure. , 2010, Contributions to nephrology.
[14] M. Dünser,et al. How to protect the heart in septic shock: a hypothesis on the pathophysiology and treatment of septic heart failure. , 2010, Medical hypotheses.
[15] M. Singer,et al. Cardioprotection, attenuated systemic inflammation, and survival benefit of &bgr;1-adrenoceptor blockade in severe sepsis in rats* , 2010, Critical care medicine.
[16] J. Cavaillon,et al. Resilience to bacterial infection: difference between species could be due to proteins in serum. , 2010, The Journal of infectious diseases.
[17] R. Bellomo,et al. Angiotensin II in experimental hyperdynamic sepsis , 2009, Critical care.
[18] R. Bellomo,et al. Septic shock induces distinct changes in sympathetic nerve activity to the heart and kidney in conscious sheep. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.
[19] M. Bucher,et al. INHIBITION OF NF-&kgr;B ACTIVITY PREVENTS DOWNREGULATION OF &agr;1-ADRENERGIC RECEPTORS AND CIRCULATORY FAILURE DURING CLP-INDUCED SEPSIS , 2009, Shock.
[20] Martin W Dünser,et al. Sympathetic Overstimulation During Critical Illness: Adverse Effects of Adrenergic Stress , 2009, Journal of intensive care medicine.
[21] C. Coopersmith,et al. The sepsis seesaw: tilting toward immunosuppression , 2009, Nature Medicine.
[22] B. Funke,et al. Central sympatholytics prolong survival in experimental sepsis , 2009, Critical care.
[23] Smitha Yerrum,et al. beta2 Adrenoreceptor blockade attenuates the hyperinflammatory response induced by traumatic injury. , 2009, Surgery.
[24] P. Radermacher,et al. Renal haemodynamic, microcirculatory, metabolic and histopathological responses to peritonitis-induced septic shock in pigs , 2008, Critical care.
[25] N. Nakagawa,et al. EXPERIMENTAL MODELS OF SEPSIS AND THEIR CLINICAL RELEVANCE , 2008, Shock.
[26] R. Bellomo,et al. Early acute kidney injury and sepsis: a multicentre evaluation , 2008, Critical care.
[27] A. A. Romanovsky,et al. Fever response to intravenous prostaglandin E2 is mediated by the brain but does not require afferent vagal signaling. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.
[28] R. Bellomo,et al. The histopathology of septic acute kidney injury: a systematic review , 2008, Critical care.
[29] A. Guillouzo,et al. Catecholamines induce an inflammatory response in human hepatocytes , 2008, Critical care medicine.
[30] T. Ravikumar,et al. Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. , 2007, American journal of respiratory and critical care medicine.
[31] A. Cauwels. Nitric oxide in shock. , 2007, Kidney international.
[32] D. Nance,et al. Autonomic innervation and regulation of the immune system (1987–2007) , 2007, Brain, Behavior, and Immunity.
[33] R. Bellomo,et al. Renal blood flow and function during recovery from experimental septic acute kidney injury , 2007, Intensive Care Medicine.
[34] R. Bassel-Duby,et al. Role of interleukin-6 in cardiac inflammation and dysfunction after burn complicated by sepsis. , 2007, American journal of physiology. Heart and circulatory physiology.
[35] M. Schedlowski,et al. beta-Adrenergic blockade during systemic inflammation: impact on cellular immune functions and survival in a murine model of sepsis. , 2007, Resuscitation.
[36] D. Rittirsch,et al. The disconnect between animal models of sepsis and human sepsis , 2007, Journal of leukocyte biology.
[37] R. Bellomo,et al. Renal Vascular Resistance in Sepsis , 2006, Nephron Physiology.
[38] R. Bellomo,et al. Effect of Low-Dose Vasopressin Infusion on Vital Organ Blood Flow in the Conscious Normal and Septic Sheep , 2006, Anaesthesia and intensive care.
[39] T. Ravikumar,et al. Ghrelin inhibits sympathetic nervous activity in sepsis. , 2006, American journal of physiology. Endocrinology and metabolism.
[40] R. Bellomo,et al. Renal blood flow in experimental septic acute renal failure. , 2006, Kidney international.
[41] Didier Payen,et al. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study* , 2006, Critical care medicine.
[42] W. Abelmann,et al. Propranolol ameliorates and epinephrine exacerbates progression of acute and chronic viral myocarditis. , 2005, American journal of physiology. Heart and circulatory physiology.
[43] Ping Wang,et al. Sympathetic excitotoxicity in sepsis: pro-inflammatory priming of macrophages by norepinephrine. , 2005, Frontiers in bioscience : a journal and virtual library.
[44] C. Vayssettes-Courchay,et al. Sympathetic activation and tachycardia in lipopolysaccharide treated rats are temporally correlated and unrelated to the baroreflex , 2005, Autonomic Neuroscience.
[45] R. Bellomo,et al. Renal blood flow in sepsis , 2005, Critical care.
[46] F. Haddy,et al. Acute renal failure and sepsis. , 2004, The New England journal of medicine.
[47] K. Denton,et al. Predominant postglomerular vascular resistance response to reflex renal sympathetic nerve activation during ANG II clamp in rabbits. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.
[48] Y. Takemoto,et al. Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats , 2004, Critical care medicine.
[49] C. Esmon,et al. Why do animal models (sometimes) fail to mimic human sepsis? , 2004, Critical care medicine.
[50] F. Coluzzi,et al. Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock , 2004, Intensive Care Medicine.
[51] J. Bakker,et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock* , 2004, Critical care medicine.
[52] R. Bellomo,et al. Vital organ blood flow during hyperdynamic sepsis. , 2003, Chest.
[53] R. Bellomo,et al. Norepinephrine and vital organ blood flow during experimental hyperdynamic sepsis , 2003, Intensive Care Medicine.
[54] Mitchell M. Levy,et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.
[55] D. Chittock,et al. Beneficial Effects of Short-term Vasopressin Infusion during Severe Septic Shock , 2002, Anesthesiology.
[56] R. Weiss,et al. Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. , 2001, American journal of physiology. Heart and circulatory physiology.
[57] D. Chinkes,et al. Reversal of catabolism by beta-blockade after severe burns. , 2001, The New England journal of medicine.
[58] G. Clermont,et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.
[59] H. Baba,et al. Cardiac remodeling after long term norepinephrine treatment in rats. , 2001, Cardiovascular research.
[60] R. Bellomo,et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial , 2000, The Lancet.
[61] K. Denton,et al. Effects of angiotensin II on regional afferent and efferent arteriole dimensions and the glomerular pole. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.
[62] K. Giercksky,et al. Nitric oxide indices in human septic shock , 2000, Critical care medicine.
[63] C. Liang,et al. Alterations by norepinephrine of cardiac sympathetic nerve terminal function and myocardial beta-adrenergic receptor sensitivity in the ferret: normalization by antioxidant vitamins. , 2000, Circulation.
[64] M. Kim,et al. The Effect of Clonidine Pretreatment on the Perioperative Proinflammatory Cytokines, Cortisol, and ACTH Responses in Patients Undergoing Total Abdominal Hysterectomy , 2000, Anesthesia and analgesia.
[65] P. Sipkema,et al. Interaction of oxyradicals, antioxidants, and nitric oxide during sepsis , 2000, Critical care medicine.
[66] K. Tracey,et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin , 2000, Nature.
[67] D. Annane,et al. Compartmentalised inducible nitric-oxide synthase activity in septic shock , 2000, The Lancet.
[68] I. Chaudry,et al. Kupffer cells are responsible for producing inflammatory cytokines and hepatocellular dysfunction during early sepsis. , 1999, The Journal of surgical research.
[69] C. Saper,et al. Mechanisms of CNS response to systemic immune challenge: the febrile response , 1997, Trends in Neurosciences.
[70] D. Nance,et al. Peripheral endotoxin increases splenic sympathetic nerve activity via central prostaglandin synthesis. , 1997, The American journal of physiology.
[71] G. Jennings,et al. Adverse consequences of high sympathetic nervous activity in the failing human heart. , 1995, Journal of the American College of Cardiology.
[72] R. Landmann,et al. Beta-adrenergic receptors in human leukocyte subpopulations. , 1992, European journal of clinical investigation.
[73] K. Denton,et al. Morphometric analysis of the actions of angiotensin II on renal arterioles and glomeruli. , 1992, The American journal of physiology.
[74] J. Parrillo,et al. Detection of renal blood flow abnormalities in septic and critically ill patients using a newly designed indwelling thermodilution renal vein catheter. , 1990, Chest.
[75] K. Demarest,et al. Comparison of intracerebroventricular and intracarotid infusions of PGE2 in conscious sheep. , 1989, The American journal of physiology.
[76] S. Lundin,et al. Changes in renal sympathetic nerve activity during experimental septic and endotoxin shock in conscious rats. , 1988, Circulatory shock.
[77] M. Iriki,et al. Renal and cutaneous vasomotor and respiratory rate adjustments to peripheral cold and warm stimuli and to bacterial endotoxin in conscious rabbits. , 1982, Journal of the autonomic nervous system.
[78] C. Lucas,et al. Sepsis: a mechanism for vasodilatation in the kidney. , 1973, Annals of surgery.
[79] R. Meek,et al. Plasma Catechofamines in Patients with Serious Postoperative Infection , 1973, Annals of surgery.
[80] C. Lucas,et al. Altered renal homeostasis with acute sepsis. Clinical significance. , 1973, Archives of surgery.
[81] A. W. den Hartog,et al. Open Access RESEARCH , 2010 .
[82] 鈴木 武志. Infusion of the β-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats , 2006 .
[83] D. Breimer,et al. Pharmacological investigations on lipopolysaccharide-induced permeability changes in the blood-brain barrier in vitro. , 2003, Microvascular research.
[84] J. Berk,et al. The treatment of shock with beta adrenergic blockade. , 1972, Archives of surgery.